Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The introduction of human immunoglobulin gene segments in their unrearranged configuration into the germ line of mice might allow the production of a repertoire of human antibodies. Such transgenic mice could be used for the production of human monoclonal antibodies against human antigens. To test the feasibility of this approach, mice were created that carry a human heavy-chain minilocus comprising unrearranged immunoglobulin variable, diversity, and joining elements linked to a human mu-chain gene. The gene segments of this minilocus are rearranged in a large proportion of cells in thymus and spleen but not in nonlymphoid tissue. Some 4% of the B lymphocytes synthesize human mu chains resulting in a serum titer of about 50 micrograms of transgenic IgM antibody per ml. Hybridomas were established from the transgenic mice that stably secreted several micrograms of antibodies containing human mu heavy chains per milliliter.

Original publication

DOI

10.1073/pnas.86.17.6709

Type

Journal article

Journal

Proc Natl Acad Sci U S A

Publication Date

09/1989

Volume

86

Pages

6709 - 6713

Keywords

Animals, Antibodies, Monoclonal, B-Lymphocytes, Cell Line, Genes, Immunoglobulin, Humans, Hybridomas, Immunoglobulin Heavy Chains, Immunoglobulin mu-Chains, Mice, Mice, Transgenic, Restriction Mapping, Spleen, Thymus Gland